July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Outcomes of repeat selective laser trabeculoplasty for open-angle glaucoma
Author Affiliations & Notes
  • Saumya Copparam
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Brandon Kuley
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Cindy X Zheng
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Michael Lin
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Stephen J Moster
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Courtland Schmidt
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Marlene Moster
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Daniel Lee
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Michael J Pro
    Glaucoma, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Saumya Copparam, None; Brandon Kuley, None; Cindy Zheng, None; Michael Lin, None; Stephen Moster, None; Courtland Schmidt, None; Marlene Moster, Aeon Astron (F), Aerie Pharmaceuticals (F), Alcon Laboratories, Inc. (C), Allergan, Inc (F), Bausch & Lomb (F), Glaukos (F), InnFocus (F), IOP Ophthalmics (F), Iridex (F), Merck (C), New World Medical (F), QURA-C (C), Solex (F), TBI (F), Valeant (F); Daniel Lee, None; Michael Pro, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 689. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Saumya Copparam, Brandon Kuley, Cindy X Zheng, Michael Lin, Stephen J Moster, Courtland Schmidt, Marlene Moster, Daniel Lee, Michael J Pro; Outcomes of repeat selective laser trabeculoplasty for open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2019;60(9):689.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Selective laser trabeculoplasty (SLT) is a commonly used office procedure to reduce intraocular pressure (IOP) in patients with glaucoma, but the effect of SLT decreases with time. The purpose of this study was to determine outcomes of repeat SLT in patients with open-angle glaucoma.

Methods : A retrospective chart review of all patients who underwent SLT by 3 glaucoma specialists (CS, MRM, MJP) at Wills Eye Glaucoma from 2014 to 2018 was performed. All patients were diagnosed with open-angle glaucoma and had follow-up of at least 3 months. The repeat SLT group included any patient who had a second SLT treatment without any additional intervention between the two SLT treatments.

Results : A total of 887 eyes (796 primary open-angle glaucoma, 69 pseudoexfoliative glaucoma, 22 pigmentary glaucoma) were included. The mean age was 73.4 ± 11.6 years with 488 (55%) females. For the initial SLT, the mean baseline IOP was 19.8 ± 5.2 mmHg on 2.0 ± 1.3 IOP-lowering medications. The mean follow-up time was 9.3 ± 3.5 months. The mean IOP at the most recent follow-up visit was 16.1 ± 4.5 mmHg (P<0.001) on 1.8 ± 1.3 medications (P<0.001). SLT treatments ranged from 270 to 360 degrees with a mean power of 61.9 ± 25.1 mJ. Fifty-four eyes underwent repeat SLT treatment. The mean time to repeat SLT from initial SLT was 2.4 ± 1.3 years. The mean IOP prior to repeat SLT was 20.1 ± 4.4 mmHg on 2.2 ± 1.2 medications. The mean follow-up time after repeat SLT was 1.7 ± 1.0 years. The mean IOP at the most recent follow-up visit after repeat SLT was 17.1 ± 4.0 mmHg (P<0.001) on 2.1 ± 1.4 medications (P=0.46). There were no post-SLT IOP spikes after the second SLT treatment.

Conclusions : Repeat SLT is an effective treatment for the reduction of IOP in patients with open-angle glaucoma.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×